Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2025
상품코드:1889555
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
RNAi 기술 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 38억 2,000만 달러로 평가되었고, 2025년에는 44억 3,000만 달러에 달할 것으로 추정되며, CAGR 16.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 유전체 연구에 대한 자금 증가, 유전성 질환 및 희귀 질환의 유병률 상승, 기능 유전체 연구에서 RNAi 기술의 활용 확대, 유전자 침묵 기술에 대한 제약 산업의 관심이 증가하고, 산학 협력의 확대에 기인한 것으로 보입니다.
RNAi 기술 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 79억 6,000만 달러에 달할 것으로 예측되며, CAGR은 15.7%로 성장할 전망입니다. 예측 기간의 성장요인으로는 임상시험의 개시 건수 및 환자 등록수 증가, 제휴, 합병 및 라이선싱 계약 증가, 전문의료 및 정밀의료에 대한 헬스케어 지출 확대, 맞춤형 치료에 대한 수요 증가, 종양학 및 만성 간 질환의 부담 증가를 들 수 있습니다. 예측 기간 중에 예상되는 주요 동향으로는 지질 나노입자 전달 시스템의 진보, N-아세틸갈락토사민(GalNAc) 결합형 간 표적화 기술의 개발, 자기 전달형 siRNA 플랫폼의 최적화, siRNA의 인공지능 지원 설계와 오프타겟 저감, 엑소좀 매개 및 세포 투과성 펩티드 기반의 전달 방법 진전 등을 들 수 있습니다.
표적 치료제에 대한 수요 증가는 향후 수년간 RNAi 기술 시장의 성장을 이끌 것으로 예측됩니다. 표적 치료는 암 등의 질환에 있어서의 분자적 이상을 특이적으로 표적화 및 억제하도록 설계되어 있어 치료의 정밀도 향상과 건강한 세포에 대한 손상 최소화를 실현합니다. 표적 치료에 대한 관심이 증가하고 있는 배경은 개인의 유전자 프로파일에 기초한 개인화 치료를 가능하게 하는 정밀의료의 진전이 주요인입니다. RNAi 기술은 이 변화에 있어 중요한 역할을 하며, 유전성 질환 및 희귀 질환 치료를 위한 정밀한 유전자 침묵을 실현합니다. 이에 따라 높은 특이성 및 효능을 가진 치료의 개발이 촉진되고, 맞춤형 의료의 혁신이 가속화되고 있습니다. 예를 들어, 2024년 12월에 미국 유전자 및 세포 치료 학회(ASGCT)가 보고한 바에 의하면, 미국 식품 의약품국(FDA)은 2023년에 6건의 유전자 치료 제품을 승인했으며, 2022년의 5건으로부터 증가했습니다. 따라서 표적 치료제에 대한 수요 증가가 RNAi 기술 시장의 성장을 견인하고 있습니다.
RNAi 기술 시장의 주요 기업은 RNAi 치료제의 개발, 제공 및 상업화를 효율화하고 다양한 질병 영역에서 지속 가능한 프로그램 파이프라인을 확보하기 위해 플랫폼 통합 및 전략적 자금 조달 확보에 주력하고 있습니다. 전략적 자금 조달은 RNAi 기반 의약품의 연구 개발을 가속화하기 위해 벤처 자본, 업계 파트너 및 기타 이해 관계자로부터 투자를 확보하는 것을 의미합니다. 예를 들어, 2024년 10월에는 미국 바이오의약품 기업 시티 세라퓨틱스사가 ARCH 벤처 파트너스를 필두로 주요 생명 과학 투자자가 참여하는 시리즈 A 자금 조달로 1억 3,500만 달러를 조달했습니다. 이 자금은 간 이외의 조직을 고정밀도로 표적으로 하는 회사 고유의 지질 나노입자(LNP) 전달 플랫폼을 이용한 RNAi 기반 의약품의 개발에 활용됩니다. 이 혁신적인 기술은 RNAi 분야에서 역사적인 제약을 극복하기 위해 노력하고 있으며, 보다 광범위한 유전 질환에 대한 치료법의 개발을 가능하게 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 RNAi 기술 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 RNAi 기술 시장 : 성장률 분석
세계의 RNAi 기술 시장 실적 : 규모 및 성장(2019-2024년)
세계의 RNAi 기술 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 RNAi 기술 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 RNAi 기술 시장 : 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
마이크로 RNA(miRNA)
소형 간섭 리보 핵산(siRNA)
기타 제품
세계의 RNAi 기술 시장 : 배송 방법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이러스 벡터
나노입자
화학 수식
물리적 방법
세계의 RNAi 기술 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
치료제
창약
농업
진단
세계의 RNAi 기술 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약 및 생명 공학 기업
학술연구기관
위탁연구기관(CRO) 및 위탁제조기관(CMO)
세계의 RNAi 기술 시장 : 마이크로 RNA(miRNA) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
마이크로 RNA 모방체
마이크로 RNA 억제제
마이크로 RNA 발현 벡터
마이크로 RNA 프로파일링 및 정량 키트
세계의 RNAi 기술 시장 : 소형 간섭 리보 핵산(siRNA) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소형 간섭 리보 핵산 합성 이중 가닥
소형 간섭 리보 핵산 다이서 기질 분자
소형 간섭 리보 핵산 자기 전달 접합
소형 간섭 리보 핵산 N-아세틸갈락토사민 접합체
세계의 RNAi 기술 시장 : 기타 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
짧은 헤어핀 RNA 발현 구조체
RNA 간섭 스크리닝 라이브러리
RNA 간섭 트랜스펙션 시약
마이크로 RNA 및 siRNA 조사 키트
제7장 지역별 및 국가별 분석
세계의 RNAi 기술 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 RNAi 기술 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
RNAi 기술 시장 : 경쟁 구도
RNAi 기술 시장 : 기업 프로파일
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Revvity Inc.
QIAGEN NV
Alnylam Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
GenScript Biotech Corporation
Promega Corporation
Arrowhead Pharmaceuticals Inc.
Silence Therapeutics plc
Creative Biolabs Inc.
Bioneer Corporation
Genevant Sciences Ltd.
Gradalis Inc.
Altogen Labs LLC
Sirnaomics Inc.
Altogen Biosystems Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
RNAi 기술 시장(2009년) : 새로운 기회를 제공하는 국가
RNAi 기술 시장(2009년) : 새로운 기회를 제공하는 부문
RNAi 기술 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Ribonucleic acid interference (RNAi) technology is a biological mechanism that regulates gene expression by using small RNA molecules to silence specific messenger RNA (mRNA) sequences. By controlling gene activity, it enables scientists to suppress or reduce the production of targeted proteins. This makes RNAi a powerful tool for inhibiting disease-related genes and supports genetic research, drug development, and therapeutic applications.
The main products in ribonucleic acid interference (RNAi) technology include micro ribonucleic acid (miRNA), small interfering ribonucleic acid (siRNA), and others. Micro ribonucleic acid (miRNA) consists of short, non-coding RNA molecules that bind to complementary mRNA sequences to block translation or promote degradation, thereby fine-tuning gene expression. Delivery methods include viral vectors, nanoparticles, chemical modifications, and physical techniques, with applications across therapeutics, drug discovery, agriculture, and diagnostics. RNAi technology is widely used by pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations (CROs) and contract manufacturing organizations (CMOs).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The ribonucleic acid interference (RNAi) technology market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid interference (RNAi) technology market statistics, including ribonucleic acid interference (RNAi) technology industry global market size, regional shares, competitors with a ribonucleic acid interference (RNAi) technology market share, detailed ribonucleic acid interference (RNAi) technology market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid interference (RNAi) technology industry. This ribonucleic acid interference (RNAi) technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid interference (RNAi) technology market size has grown rapidly in recent years. It will grow from $3.82 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. Growth in the historic period can be attributed to increasing funding for genomics research, the rising prevalence of genetic and rare diseases, greater use of RNA interference in functional genomics studies, growing pharmaceutical interest in gene-silencing technologies, and expanding academic-industry collaborations.
The ribonucleic acid interference (RNAi) technology market size is expected to see rapid growth in the next few years. It will grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. Growth in the forecast period can be attributed to a rise in clinical trial initiations and patient enrollment, increasing partnerships, mergers, and licensing agreements, growing healthcare spending on specialty and precision medicines, rising demand for personalized therapies, and the increasing burden of oncology and chronic liver diseases. Major trends expected in the forecast period include advancements in lipid nanoparticle delivery systems, development of N-acetylgalactosamine (GalNAc)-conjugate liver-targeting technologies, optimization of self-delivering siRNA platforms, artificial-intelligence-assisted design and off-target reduction for siRNA, and progress in exosome-mediated and cell-penetrating peptide-based delivery methods.
The increasing demand for targeted therapeutics is expected to drive the growth of the ribonucleic acid interference (RNAi) technology market in the coming years. Targeted therapies are designed to specifically target and inhibit molecular abnormalities in diseases such as cancer, improving treatment precision and minimizing harm to healthy cells. The rising emphasis on targeted therapies is primarily fueled by advancements in precision medicine, which enable personalized treatments based on an individual's genetic profile. RNAi technology plays a crucial role in this shift, enabling precise gene silencing to treat genetic and rare diseases. It supports the development of highly specific and effective treatments, spurring innovation in personalized medicine. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT) reported that the U.S. Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the growing demand for targeted therapeutics is driving the expansion of the RNAi technology market.
Key players in the RNAi technology market are focusing on platform integration and securing strategic funding to streamline the development, delivery, and commercialization of RNAi therapeutics, ensuring a sustainable pipeline of programs across various disease areas. Strategic funding refers to securing investment from venture capital, industry partners, and other stakeholders to accelerate the research and development of RNAi-based medicines. For instance, in October 2024, City Therapeutics Inc., a US-based biopharmaceutical company, raised $135 million in Series A financing, led by ARCH Venture Partners with participation from other major life sciences investors. This funding will help develop RNAi-based medicines using the company's proprietary lipid nanoparticle (LNP) delivery platform, which is designed to target tissues beyond the liver with high precision. This innovation aims to address a historical limitation in the RNAi field, enabling the development of therapies for a broader range of genetic disorders.
In July 2023, Novartis AG, a Swiss pharmaceutical company, acquired DTx Pharma Inc. for an undisclosed amount. This acquisition aims to strengthen Novartis' RNAi therapeutic capabilities and expand its neuromuscular disease portfolio through DTx Pharma's FALCON delivery platform. DTx Pharma, a US-based preclinical-stage biotechnology company, specializes in RNA interference technology for the development of RNAi-based therapeutics.
North America was the largest region in the ribonucleic acid interference (RNAi) technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid interference (RNAi) technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ribonucleic acid interference (RNAi) technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid interference (RNAi) technology consists of revenues earned by entities by providing services such as gene silencing services, custom ribonucleic acid (RNA) synthesis, oligonucleotide design, ribonucleic acid (RNA) sequencing, target validation, functional genomics screening, data analysis, drug discovery support, delivery system optimization, and molecular assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA interference (RNAi) technology market also includes sales of microRNA mimics, transfection reagents, ribonucleic acid (RNA) delivery kits, plasmid vectors, assay kits, cell lines, reagents and buffers, and laboratory consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ribonucleic acid interference (rnai) technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ribonucleic acid interference (rnai) technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid interference (rnai) technology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Micro Ribonucleic Acid (miRNA); Small Interfering Ribonucleic Acid (siRNA); Other Products
2) By Delivery Method: Viral Vectors; Nanoparticles; Chemical Modifications; Physical Methods
3) By Application: Therapeutics; Drug Discovery; Agriculture; Diagnostics
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
2) By Small Interfering Ribonucleic Acid (siRNA): Small Interfering Ribonucleic Acid Synthetic Duplexes; Small Interfering Ribonucleic Acid Dicer Substrate Molecules; Small Interfering Ribonucleic Acid Self Delivering Conjugates; Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
3) By Other Products: Short Hairpin Ribonucleic Acid Expression Constructs; Ribonucleic Acid Interference Screening Libraries; Ribonucleic Acid Interference Transfection Reagents; Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits
3. Ribonucleic Acid Interference (RNAi) Technology Market Trends And Strategies
4. Ribonucleic Acid Interference (RNAi) Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Ribonucleic Acid Interference (RNAi) Technology Growth Analysis And Strategic Analysis Framework
5.1. Global Ribonucleic Acid Interference (RNAi) Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Micro Ribonucleic Acid (miRNA)
Small Interfering Ribonucleic Acid (siRNA)
Other Products
6.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Vectors
Nanoparticles
Chemical Modifications
Physical Methods
6.3. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutics
Drug Discovery
Agriculture
Diagnostics
6.4. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
6.5. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Micro Ribonucleic Acid Mimics
Micro Ribonucleic Acid Inhibitors
Micro Ribonucleic Acid Expression Vectors
Micro Ribonucleic Acid Profiling And Quantification Kits
6.6. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Interfering Ribonucleic Acid Synthetic Duplexes
Small Interfering Ribonucleic Acid Dicer Substrate Molecules
Small Interfering Ribonucleic Acid Self Delivering Conjugates
Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
6.7. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short Hairpin Ribonucleic Acid Expression Constructs
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ribonucleic Acid Interference (RNAi) Technology Market
9.1. China Ribonucleic Acid Interference (RNAi) Technology Market Overview
9.2. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ribonucleic Acid Interference (RNAi) Technology Market
10.1. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ribonucleic Acid Interference (RNAi) Technology Market
11.1. Japan Ribonucleic Acid Interference (RNAi) Technology Market Overview
11.2. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ribonucleic Acid Interference (RNAi) Technology Market
12.1. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market
13.1. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ribonucleic Acid Interference (RNAi) Technology Market
14.1. South Korea Ribonucleic Acid Interference (RNAi) Technology Market Overview
14.2. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market
15.1. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
15.2. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ribonucleic Acid Interference (RNAi) Technology Market
16.1. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market
21.1. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
21.2. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ribonucleic Acid Interference (RNAi) Technology Market
22.1. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ribonucleic Acid Interference (RNAi) Technology Market
23.1. North America Ribonucleic Acid Interference (RNAi) Technology Market Overview
23.2. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ribonucleic Acid Interference (RNAi) Technology Market
24.1. USA Ribonucleic Acid Interference (RNAi) Technology Market Overview
24.2. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ribonucleic Acid Interference (RNAi) Technology Market
26.1. South America Ribonucleic Acid Interference (RNAi) Technology Market Overview
26.2. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ribonucleic Acid Interference (RNAi) Technology Market
27.1. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ribonucleic Acid Interference (RNAi) Technology Market
28.1. Middle East Ribonucleic Acid Interference (RNAi) Technology Market Overview
28.2. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ribonucleic Acid Interference (RNAi) Technology Market
29.1. Africa Ribonucleic Acid Interference (RNAi) Technology Market Overview
29.2. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ribonucleic Acid Interference (RNAi) Technology Market Competitive Landscape And Company Profiles
